Skip to main content
. 2017 May 8;25(4):620–624. doi: 10.1016/j.jsps.2017.04.034

Fig. 3.

Fig. 3

Growth curve of HaCaT cells. MTS assay of the viability of HaCaT cells treated with STAT1-siRNA or STAT3-siRNA (50 nM) in presence or absence of acitretin (5 μM) for 12, 24, 48 and 72 h.